PlainPharmaWatch

CMS Open Payments · Tool

Asahi Intecc Co., Ltd. vs Volpara Health, Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Volpara Health, Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 6,645, versus 1,670 for the other company. Its single largest recorded recipient represents 80.9% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Asahi Intecc Co., Ltd.
HHI 1,670 · top recipient 23.8%
Ranked #823 of 1,838 companies by HHI
Volpara Health, Inc
HHI 6,645 · top recipient 80.9%
Ranked #238 of 1,838 companies by HHI

Payment Overview

Total Payments
$150.9K
% of Industry
0.0%
Transactions
72
Avg per Transaction
$2.1K
Recipients
72
Avg per Recipient
$2.1K
Payment Types
6
Top Payment Type
Consulting Fee
Total Payments
$152.0K
% of Industry
0.0%
Transactions
29
Avg per Transaction
$5.2K
Recipients
29
Avg per Recipient
$5.2K
Payment Types
3
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Asahi Intecc Co., Ltd. vs Volpara Health, Inc - total reported payments in CMS Open Payments PY2024

Volpara Health, Inc$152.0KAsahi Intecc Co., Ltd.$150.9K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Asahi Intecc Co., Ltd.

Consulting Fee $69.3K

45.9%

Royalty or License $28.0K

18.6%

Travel and Lodging $25.5K

16.9%

Grant $22.3K

14.8%

Food and Beverage $5.0K

3.3%

Honoraria $957.00

0.6%

Volpara Health, Inc

Royalty or License $143.3K

94.2%

Consulting Fee $6.0K

3.9%

Food and Beverage $2.7K

1.8%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Asahi Intecc Co., Ltd.

  1. 1

    JIHAD MUSTAPHA

    $36,000.00 · 2 txns

  2. 2

    ADNAN SIDDIQUI

    $30,289.60 · 8 txns

  3. 3

    WILLIAM LOMBARDI

    $28,283.64 · 2 txns

  4. 4

    Univ Of Missouri Health Care

    $22,284.00 · 1 txns

  5. 5

    AMEER HASSAN

    $12,573.54 · 7 txns

Volpara Health, Inc

  1. 1

    Boca Raton Regional Hospital

    $123,000.00 · 2 txns

  2. 2

    Strong Memorial Hospital

    $11,588.00 · 2 txns

  3. 3

    Northside Hospital - Gwinnett

    $8,333.33 · 1 txns

  4. 4

    Mount Sinai Medical Center Of Florid

    $3,000.00 · 1 txns

  5. 5

    East Alabama Medical Center

    $3,000.00 · 1 txns

Summary Comparison

Metric Asahi Intecc Co., Ltd. Volpara Health, Inc
Total Payments $150.9K $152.0K
% of Industry Total 0.0% 0.0%
Transaction Count 72 29
Avg per Transaction $2.1K $5.2K
Recipient Count 72 29
Avg per Recipient $2.1K $5.2K
Payment Type Count 6 3
Top Payment Type Consulting Fee Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.